Australia Hits Pfizer With Antitrust Suit Over Lipitor

Law360, New York (February 13, 2014, 1:06 PM EST) -- Australia's competition regulator has sued the domestic unit of Pfizer Inc. over its marketing of the cholesterol-lowering drug Lipitor to pharmacies as the patent protection for the drug was about to expire, alleging the manufacturer abused its market power, the country's antitrust watchdog announced Thursday.

The Australian Competition and Consumer Commission alleged that financial incentives Pfizer Australia Pty Ltd. offered to retailers to stock up on a large supply of Lipitor and Pfizer's own generic form of the drug, atorvastatin, before it faced competition from generic-drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.